[Form 3] Basel Medical Group Ltd Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Basel Medical Group Ltd Chief Executive Officer Chhoa Darren Yen Feng has filed an initial Form 3, which is a statement of beneficial ownership for company insiders. This filing excerpt shows no reported transactions and no listed derivative positions for the reporting person.

Key Terms

Form 3, beneficial ownership, derivative positions

3 terms

Form 3 regulatory

"has filed an initial Form 3, which is a statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"initial Form 3, which is a statement of beneficial ownership for company insiders"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

derivative positions financial

"This filing excerpt shows no reported transactions and no listed derivative positions"

Derivative positions are contracts that derive their value from an underlying asset—such as a stock, bond, currency or commodity—and include instruments like options, futures and swaps. Think of them as bets or insurance tied to an asset’s future price: they let investors amplify returns, hedge risk or take exposure without owning the asset directly, which can meaningfully increase potential gains, losses and volatility in a portfolio.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chhoa Darren Yen Feng

(Last) (First) (Middle)

6 NAPIER ROAD,

UNIT #02-10/11 GLENEAGLES MEDICAL CENTRE

(Street)

SINGAPORE 258499

(City) (State) (Zip)

SINGAPORE

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Basel Medical Group Ltd [ BMGL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Darren Yen Feng Chhoa	04/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Basel Medical Group (BMGL) Form 3 filing show?

The Form 3 filing shows that CEO Chhoa Darren Yen Feng has submitted an initial statement of beneficial ownership. In this excerpt, there are no reported transactions or derivative positions listed for the reporting person.

Who is the reporting person in Basel Medical Group (BMGL) Form 3?

The reporting person is Chhoa Darren Yen Feng, who serves as Chief Executive Officer of Basel Medical Group Ltd. The filing identifies him as an officer, not a director or ten-percent owner, in this initial ownership report.

Does the BMGL Form 3 show any insider buying or selling activity?

No insider buying or selling activity appears in this Form 3 excerpt. The transaction summary shows zero buy, sell, acquire, dispose, and exercise transactions, indicating no reportable trading activity covered by this particular filing segment.

Are there any derivative securities reported in Basel Medical Group (BMGL) Form 3?

No derivative securities are reported in this excerpt. The derivativeSummary is empty, and the transaction summary lists zero derivative transactions, suggesting no options, warrants, or similar instruments disclosed here.

What is the purpose of this Basel Medical Group (BMGL) Form 3?

This Form 3 serves as an initial statement of beneficial ownership for CEO Chhoa Darren Yen Feng. It formally registers his status as a reporting person under SEC rules, even though no specific holdings or transactions are detailed in the excerpt.